Peter Hillmen, Joris Diels, Nollaig Healy, Wafae Iraqi, Johan Aschan, Mark Wildgust. Ibrutinib for chronic lymphocytic leukemia: international experience from a named patient program. Haematologica 2018;103(5):e204-e206; https://doi.org/10.3324/haematol.2017.178798.